Legend Biotech Corp (LEGN)
47.44
+0.36
(+0.76%)
USD |
NASDAQ |
Apr 23, 15:59
Legend Biotech Debt to Equity Ratio: 0.2248 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.2248 |
| September 30, 2023 | 0.206 |
| June 30, 2023 | 0.1923 |
| March 31, 2023 | 0.407 |
| December 31, 2022 | 0.3506 |
| September 30, 2022 | |
| June 30, 2022 | 0.3363 |
| March 31, 2022 | 0.2889 |
| December 31, 2021 | 0.1573 |
| Date | Value |
|---|---|
| September 30, 2021 | 0.3123 |
| June 30, 2021 | 0.0509 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Dec 2019
0.407
Maximum
Mar 2023
0.1579
Average
0.1748
Median
Debt to Equity Ratio Benchmarks
| Johnson & Johnson | 0.4265 |
| Bristol-Myers Squibb Co | 1.351 |
| 2seventy bio Inc | 0.00 |
| Gilead Sciences Inc | 1.094 |
| Exelixis Inc | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.849B |
| Total Liabilities (Quarterly) | 597.24M |
| Shareholders Equity (Quarterly) | 1.251B |
| Current Ratio | 6.921 |
| Net Debt Paydown Yield | -0.51% |